118 related articles for article (PubMed ID: 28266626)
1. Anordrin Eliminates Tamoxifen Side Effects without Changing Its Antitumor Activity.
Gu W; Xu W; Sun X; Zeng B; Wang S; Dong N; Zhang X; Chen C; Yang L; Chen G; Xin A; Ni Z; Wang J; Yang J
Sci Rep; 2017 Mar; 7():43940. PubMed ID: 28266626
[TBL] [Abstract][Full Text] [Related]
2. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen-induced uterine abnormalities: the role of imaging.
Ascher SM; Imaoka I; Lage JM
Radiology; 2000 Jan; 214(1):29-38. PubMed ID: 10644098
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen and secondary tumours. An update.
Wilking N; Isaksson E; von Schoultz E
Drug Saf; 1997 Feb; 16(2):104-17. PubMed ID: 9067122
[TBL] [Abstract][Full Text] [Related]
5. Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients.
Chang HT; Pan HJ; Lee CH
Clin Breast Cancer; 2018 Aug; 18(4):e677-e685. PubMed ID: 29287963
[TBL] [Abstract][Full Text] [Related]
6. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary note.
Kuwashima Y; Kurosumi M; Kobayashi Y; Tanuma J; Suemasu K; Higashi Y; Kasamatsu T; Shiromizu K; Matsuzawa M; Kishi K
Anticancer Res; 1996; 16(5A):2993-6. PubMed ID: 8917418
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of tamoxifen-associated endometrial cancer.
Lasset C; Mignotte H; Bonadona V; Chauvin F
J Clin Oncol; 1998 Jul; 16(7):2573. PubMed ID: 9667283
[No Abstract] [Full Text] [Related]
9. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
Swerdlow AJ; Jones ME;
J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
[TBL] [Abstract][Full Text] [Related]
10. Antiestrogenic and antifertility actions of Anordrin (2 alpha, 17 alpha-diethynyl-A-nor-5 alpha-androstane-2 beta, 17 beta-diol 2,17-dipropionate).
Mehta RR; Jenco JM; Chatterton RT
Steroids; 1981 Dec; 38(6):679-91. PubMed ID: 7336465
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen and the uterus.
Vergote I; Neven P; Vanderick G; van Dam P; Van Belle Y; De Sutter Ph; De Prins F; De Muylder X; Claerhout J; Campo R; Albertyn G
Eur J Cancer; 1998 Aug; 34 Suppl 4():S1-3. PubMed ID: 9917139
[No Abstract] [Full Text] [Related]
12. [Tamoxifen and giant endometrial polyps].
Caschetto S; Cassaro N; Consalvo P; Caragliano L
Minerva Ginecol; 2000 Nov; 52(11):459-63. PubMed ID: 11256174
[TBL] [Abstract][Full Text] [Related]
13. [Drug-induced Nonalcoholic Steatohepatitis].
Miyamura M; Yokota J; Saibara T
Yakugaku Zasshi; 2016; 136(4):579-82. PubMed ID: 27040342
[TBL] [Abstract][Full Text] [Related]
14. Antiestrogen therapy: uncertainties and risk assessment.
Smith LL; White IN
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):14-22. PubMed ID: 9556786
[TBL] [Abstract][Full Text] [Related]
15. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen and the uterus. Proceedings of an international meeting. Brussels, Belgium, 12-13 December 1997.
Eur J Cancer; 1998 Aug; 34 Suppl 4():S1-67. PubMed ID: 9887891
[No Abstract] [Full Text] [Related]
17. Effects of anordrin and its analogue on antifertility.
Liu CQ; Chen BL; Shen SR; Zhang GZ; Dai MZ
Contraception; 1985 Sep; 32(3):301-9. PubMed ID: 3841308
[TBL] [Abstract][Full Text] [Related]
18. Should tamoxifen users be screened for endometrial lesions?
Neven P; Vergote I
Lancet; 1998 Jan; 351(9097):155-7. PubMed ID: 9449866
[No Abstract] [Full Text] [Related]
19. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]